谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors

Toshio Shimizu,Takako Eguchi Nakajima,Noboru Yamamoto,Kan Yonemori,Takafumi Koyama,Shunsuke Kondo,Yu Sunakawa, Naoki Izawa,Yoshiki Horie,Silong Xiang,Siying Xu, Lan Qin,John Gong, David Liu

Investigational New Drugs（2022）

引用 5|浏览13
暂无评分
关键词
Envafolimab, Subcutaneous, Programmed death-ligand 1, Immunotherapy, Japanese
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要